Who is sponsoring NCT06356857?

NCT06356857 is sponsored by Peter Hovind.

What drugs are being tested in NCT06356857?

Interventions in NCT06356857: Myocardial perfusion imaging (MPI) using [O15]H2O-PET-CT.

What condition does NCT06356857 study?

NCT06356857 studies Myocardial Blood Flow.

Is NCT06356857 still recruiting?

NCT06356857 is currently active, enrolled. Last updated 6 April 2025.

Last reviewed 2025-04-06 · How we verify

NCT06356857: Heart-Wave

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessing Repeatability and Intra-individual Variability in [O15]H2O-PET Myocardial Perfusion Imaging

Active, enrolled Last updated 6 April 2025

What this trial tests

trial testing Myocardial perfusion imaging (MPI) using [O15]H2O-PET-CT in Myocardial Blood Flow in 20 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

15 April 2024

Primary endpoint
17 March 2025

17 March 2026

Quick facts

Lead sponsor	Peter Hovind
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	20
Start date	15 April 2024
Primary completion	17 March 2025
Estimated completion	17 March 2026
Sites	1 location across Denmark

Drugs / interventions tested

Myocardial perfusion imaging (MPI) using [O15]H2O-PET-CT

Conditions studied

Myocardial Blood Flow — all drugs for Myocardial Blood Flow →

Sponsor

Peter Hovind

Who can join

50 and older, any sex, with Myocardial Blood Flow. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study wish to assess the reproducibility of baseline and hyperemic myocardial blood flow as well as myocardial blood flow reserve measurements with \[O15\]H2O-PET-MPI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06356857 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peter Hovind
Last refreshed: 6 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06356857.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing